Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation

被引:51
作者
Shen, Chih-Che [1 ]
Hsu, Mu-Nung [1 ]
Chang, Chin-Wei [1 ]
Lin, Mei-Wei [1 ,2 ]
Hwu, Jih-Ru [3 ,4 ]
Tu, Yi [5 ]
Hu, Yu-Chen [1 ,4 ]
机构
[1] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan
[2] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan
[3] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan
[4] Natl Tsing Hua Univ, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu, Taiwan
[5] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan
关键词
HUMAN-CELLS; GENOME; DELIVERY; GENE; NUCLEASES; SYSTEM; DNA; RIBONUCLEOPROTEIN; TECHNOLOGIES; SPECIFICITY;
D O I
10.1093/nar/gky1165
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR/Cas9 is a powerful genome editing system but uncontrolled Cas9 nuclease expression triggers off-target effects and even in vivo immune responses. Inspired by synthetic biology, here we built a synthetic switch that self-regulates Cas9 expression not only in the transcription step by guide RNA-aided self-cleavage of cas9 gene, but also in the translation step by L7Ae:K-turn repression system. We showed that the synthetic switch enabled simultaneous transcriptional and translational repression, hence stringently attenuating the Cas9 expression. The restricted Cas9 expression induced high efficiency on-target indel mutation while minimizing the off-target effects. Furthermore, we unveiled the correlation between Cas9 expression kinetics and on-target/off-target mutagenesis. The synthetic switch conferred detectable Cas9 expression and concomitant high frequency on-target mutagenesis at as early as 6 h, and restricted the Cas9 expression and off-target effects to minimal levels through 72 h. The synthetic switch is compact enough to be incorporated into viral vectors for self-regulation of Cas9 expression, thereby providing a novel hit and run' strategy for in vivo genome editing.
引用
收藏
页数:11
相关论文
共 66 条
[31]   CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences [J].
Lin, Yanni ;
Cradick, Thomas J. ;
Brown, Matthew T. ;
Deshmukh, Harshavardhan ;
Ranjan, Piyush ;
Sarode, Neha ;
Wile, Brian M. ;
Vertino, Paula M. ;
Stewart, Frank J. ;
Bao, Gang .
NUCLEIC ACIDS RESEARCH, 2014, 42 (11) :7473-7485
[32]   A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing [J].
Liu, Kaiwen Ivy ;
Ramli, Muhammad Nadzim Bin ;
Woo, Cheok Wei Ariel ;
Wang, Yuanming ;
Zhao, Tianyun ;
Zhang, Xiujun ;
Yim, Guo Rong Daniel ;
Chong, Bao Yi ;
Gowher, Ali ;
Chua, Mervyn Zi Hao ;
Jung, Jonathan ;
Lee, Jia Hui Jane ;
Tan, Meng How .
NATURE CHEMICAL BIOLOGY, 2016, 12 (11) :980-+
[33]   Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing [J].
Lu, Jia ;
Zhao, Chen ;
Zhao, Yingze ;
Zhang, Jingfang ;
Zhang, Yue ;
Chen, Li ;
Han, Qiyuan ;
Ying, Yue ;
Peng, Shuai ;
Ai, Runna ;
Wang, Yu .
NUCLEIC ACIDS RESEARCH, 2018, 46 (05) :E25
[34]   Genome-editing Technologies for Gene and Cell Therapy [J].
Maeder, Morgan L. ;
Gersbach, Charles A. .
MOLECULAR THERAPY, 2016, 24 (03) :430-446
[35]   RNA-Guided Human Genome Engineering via Cas9 [J].
Mali, Prashant ;
Yang, Luhan ;
Esvelt, Kevin M. ;
Aach, John ;
Guell, Marc ;
DiCarlo, James E. ;
Norville, Julie E. ;
Church, George M. .
SCIENCE, 2013, 339 (6121) :823-826
[36]   In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges [J].
Mout, Rubul ;
Ray, Moumita ;
Lee, Yi-Wei ;
Scaletti, Federica ;
Rotello, Vincent M. .
BIOCONJUGATE CHEMISTRY, 2017, 28 (04) :880-884
[37]   Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome [J].
Mueller, Maximilian ;
Lee, Ciaran M. ;
Gasiunas, Giedrius ;
Davis, Timothy H. ;
Cradick, Thomas J. ;
Siksnys, Virginijus ;
Bao, Gang ;
Cathomen, Toni ;
Mussolino, Claudio .
MOLECULAR THERAPY, 2016, 24 (03) :636-644
[38]   Photoactivatable CRISPR-Cas9 for optogenetic genome editing [J].
Nihongaki, Yuta ;
Kawano, Fuun ;
Nakajima, Takahiro ;
Sato, Moritoshi .
NATURE BIOTECHNOLOGY, 2015, 33 (07) :755-760
[39]   Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing [J].
Ortinski, Pavel I. ;
O'Donovan, Bernadette ;
Dong, Xiaoyu ;
Kantor, Boris .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2017, 5 :153-164
[40]   Hit and go CAS9 delivered through a lentiviral based self-limiting circuit [J].
Petris, Gianluca ;
Casini, Antonio ;
Montagna, Claudia ;
Lorenzin, Francesca ;
Prandi, Davide ;
Romanel, Alessandro ;
Zasso, Jacopo ;
Conti, Luciano ;
Demichelis, Francesca ;
Cereseto, Anna .
NATURE COMMUNICATIONS, 2017, 8